Therapy Related Myelodysplastic Syndrome and Therapy Related Acute Myeloid Leukemia Terminated Phase 2 Trials for Gedatolisib (DB11896)

Also known as: Therapy-related Acute Myeloid Leukemia and Myelodysplastic Syndrome

IndicationStatusPhase
DBCOND0118886 (Therapy Related Myelodysplastic Syndrome and Therapy Related Acute Myeloid Leukemia)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02438761PF-05212384 (PKI-587) for t-AML/MDS or de Novo Relapsed or Refractory Acute Myeloid Leukemia (AML)Treatment